174 related articles for article (PubMed ID: 31558772)
1. Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer.
Asare-Werehene M; Communal L; Carmona E; Le T; Provencher D; Mes-Masson AM; Tsang BK
Sci Rep; 2019 Sep; 9(1):13924. PubMed ID: 31558772
[TBL] [Abstract][Full Text] [Related]
2. Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin.
Gerber E; Asare-Werehene M; Reunov A; Burger D; Le T; Carmona E; Mes-Masson AM; Tsang BK
J Ovarian Res; 2023 Jan; 16(1):14. PubMed ID: 36642715
[TBL] [Abstract][Full Text] [Related]
3. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance.
Asare-Werehene M; Nakka K; Reunov A; Chiu CT; Lee WT; Abedini MR; Wang PW; Shieh DB; Dilworth FJ; Carmona E; Le T; Mes-Masson AM; Burger D; Tsang BK
Oncogene; 2020 Feb; 39(7):1600-1616. PubMed ID: 31700155
[TBL] [Abstract][Full Text] [Related]
4. Plasma Gelsolin Inhibits Natural Killer Cell Function and Confers Chemoresistance in Epithelial Ovarian Cancer.
Onuma T; Asare-Werehene M; Fujita Y; Yoshida Y; Tsang BK
Cells; 2024 May; 13(11):. PubMed ID: 38891037
[TBL] [Abstract][Full Text] [Related]
5. The regulation of plasma gelsolin by DNA methylation in ovarian cancer chemo-resistance.
Manzoor HB; Asare-Werehene M; Pereira SD; Satyamoorthy K; Tsang BK
J Ovarian Res; 2024 Jan; 17(1):15. PubMed ID: 38216951
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Plasma Gelsolin Is an Immunosuppressive Mediator in the Ovarian Tumor Microenvironment and a Determinant of Chemoresistance.
Onuma T; Asare-Werehene M; Yoshida Y; Tsang BK
Cells; 2022 Oct; 11(20):. PubMed ID: 36291171
[TBL] [Abstract][Full Text] [Related]
7. Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes.
Asare-Werehene M; Tsuyoshi H; Zhang H; Salehi R; Chang CY; Carmona E; Librach CL; Mes-Masson AM; Chang CC; Burger D; Yoshida Y; Tsang BK
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205790
[TBL] [Abstract][Full Text] [Related]
8. Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients.
Flores Gama C; Rosales LM; Ouellet G; Dou Y; Thijssen S; Usvyat L; Zhang H; Kuntsevich V; Levin NW; Kotanko P
Blood Purif; 2017; 43(1-3):210-217. PubMed ID: 28114138
[TBL] [Abstract][Full Text] [Related]
9. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study.
Lee PS; Patel SR; Christiani DC; Bajwa E; Stossel TP; Waxman AB
PLoS One; 2008; 3(11):e3712. PubMed ID: 19002257
[TBL] [Abstract][Full Text] [Related]
10. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns].
Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY
Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of plasma gelsolin in severe burn patients with sepsis].
Huang L; Yao Y; Dong N; He L; Zhang Q; Yu Y; Sheng Z
Zhonghua Shao Shang Za Zhi; 2016 Feb; 32(2):77-81. PubMed ID: 26902273
[TBL] [Abstract][Full Text] [Related]
12. The Application of an Extracellular Vesicle-Based Biosensor in Early Diagnosis and Prediction of Chemoresponsiveness in Ovarian Cancer.
Asare-Werehene M; Hunter RA; Gerber E; Reunov A; Brine I; Chang CY; Chang CC; Shieh DB; Burger D; Anis H; Tsang BK
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174032
[TBL] [Abstract][Full Text] [Related]
13. Circulating Plasma Gelsolin: A Predictor of Favorable Clinical Outcomes in Head and Neck Cancer and Sensitive Biomarker for Early Disease Diagnosis Combined with Soluble Fas Ligand.
Chiu CT; Wang PW; Asare-Werehene M; Tsang BK; Shieh DB
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545773
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-200b in ovarian carcinoma patients: distinct pattern of pre/post-treatment variation compared to CA-125 and potential for prediction of progression-free survival.
Kapetanakis NI; Uzan C; Jimenez-Pailhes AS; Gouy S; Bentivegna E; Morice P; Caron O; Gourzones-Dmitriev C; Le Teuff G; Busson P
Oncotarget; 2015 Nov; 6(34):36815-24. PubMed ID: 26416421
[TBL] [Abstract][Full Text] [Related]
15. Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R
J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844
[TBL] [Abstract][Full Text] [Related]
16. Serum tetranectin is a significant prognostic marker in ovarian cancer patients.
Begum FD; Høgdall E; Christensen IJ; Kjaer SK; Blaakaer J; Christensen L; Høgdall C
Acta Obstet Gynecol Scand; 2010; 89(2):190-8. PubMed ID: 20121334
[TBL] [Abstract][Full Text] [Related]
17. Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
Audley J; Gliniewicz EF; Zarember KA; Hong HS; Wald G; Kuhns DB; Kang E; Malech HL; Suffredini AF; Noveck RJ; Dinubile MJ; Levinson SL; Stossel TP; Gallin JI
Inflammation; 2021 Feb; 44(1):270-277. PubMed ID: 32886268
[TBL] [Abstract][Full Text] [Related]
18. Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.
Self WH; Wunderink RG; DiNubile MJ; Stossel TP; Levinson SL; Williams DJ; Anderson EJ; Bramley AM; Jain S; Edwards KM; Grijalva CG
Clin Infect Dis; 2019 Sep; 69(7):1218-1225. PubMed ID: 30561561
[TBL] [Abstract][Full Text] [Related]
19. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage III epithelial ovarian cancer.
Venesmaa P; Stenman UH; Forss M; Leminen A; Lehtovirta P; Vartiainen J; Paavonen J
Br J Obstet Gynaecol; 1998 May; 105(5):508-11. PubMed ID: 9637119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
